Activist Oramed Sells Direct Stake, Shifts to Options Strategy After Proxy Settlement
NNDM sits 24% above its 52-week low of $1.19.
Summary
Oramed Pharmaceuticals, a former activist investor, sold its direct equity stake in Nano Dimension, reducing its beneficial ownership below 5%, but simultaneously established a new options position.
Key Events · Ownership and Investor Activity · NNDM
-
Significant Share Sale
Oramed Pharmaceuticals sold 8,200,000 ordinary shares at $1.55 per share, totaling $12.71 million.
-
Reduced Ownership Below 5%
Following the sale, Oramed Pharmaceuticals ceased to beneficially own more than five percent of Nano Dimension's outstanding shares.
-
Shift to Options Strategy
Concurrently, Oramed purchased call options and sold put options referencing 8,200,000 shares, indicating a shift from direct equity ownership to a derivative-based exposure.
-
Follows Proxy Settlement
These transactions occurred on July 20, 2026, just before the announcement of the settlement of the proxy contest between Nano Dimension and Murchinson Ltd. on July 21, 2026.
Analysis · NNDM · Manufacturing
Oramed Pharmaceuticals, a former activist shareholder, has sold its direct equity stake in Nano Dimension, reducing its beneficial ownership below 5%. This move follows the recent settlement of the proxy contest with Murchinson Ltd. and Oramed's prior opposition to a major acquisition. While Oramed sold its shares, it simultaneously entered into a complex options strategy, purchasing call options and selling put options, indicating a continued, albeit indirect, bullish exposure to the stock. This strategic shift by a significant investor marks a change in their direct involvement following a period of intense corporate governance activity.
How filings like this one have moved
In the 30 days to Sep 18, 2026, 29.1% of the 1692 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NNDM was trading at $1.48 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $309.9M. The 52-week trading range was $1.19 to $2.32. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.